ANEB - Anebulo Pharmaceuticals appoints Kenneth Cundy as chief scientific officer

Anebulo Pharmaceuticals (NASDAQ:ANEB) on Tuesday said it had appointed Kenneth Cundy as chief scientific officer. Cundy joins Anebulo from biotech company CohBar (CWBR). He had previously held various positions at Gilead Sciences (GILD). Cundy will lead ANEB’s research and development initiatives. Austin, Texas-based clinical-stage biotech Anebulo develops solutions for people suffering from substance abuse disorder and acute cannabinoid intoxication. ANEB stock -4.7% to $3.03 in aftermarket trading.

For further details see:

Anebulo Pharmaceuticals appoints Kenneth Cundy as chief scientific officer